Home
Industry & Business
Entertainment
Channels
Life Style
Gaming
Sports
Technology
World News
Trend News
Celebrities GoGreen
GreenWorld
HealthNews
Movies

News, Jobs & Trends: : Pharmaceutical:

USA Jobs|| India Jobs|| Gulf Jobs



Reader Series 1health Diabetes
Tweet Short   Submit Articles
  
Does Alcohold Decreases The Risk Of Diabetes?


Drinking Alcohol Really Does Decreases the Risk of Type 2 Diabetes Among Older Women
It is absurd. For the longest time, we have believed that alcohol has no real benefits. However, recently, a study has found that drinking moderate amounts of alcohol really does decreases the risk of Type 2 Diabetes, and this is especially true among Older Women! There are 20.8 million children and adults in the United States, or 7% of the population, who have diabetes. While an estimated 14.6 million have been diagnosed with diabetes, unfortunately, 6.2 million people (or nearly one-third) are unaware that they have the disease.

Recent studies have shown that drinking moderate amounts of alcohol (as compared to drinking too much alcohol or no alcohol at all) can lower the chances of getting type 2 diabetes. However, only a few studies on alcohol and type 2 diabetes have included women, and very few have included older women.

Previous studies on the effects of drinking moderate amounts of alcohol (1-2 drinks) and the risk of developing type 2 diabetes have mostly been done on men or both men and women who were younger than 55 years old. The researchers wanted to study how drinking alcohol affects older women’s (more than 50 years old) chances of developing type 2 diabetes. (see Diabetes Symptoms)

Questionnaires were mailed to the women in the study. The women were asked where they lived and if they had conditions that put them at risk for any other diseases. Waist and hip, height, weight, and blood pressure measurements were taken at the beginning of the study. Diabetes, high blood pressure, and high cholesterol were also reported if these conditions were diagnosed by a doctor. The questionnaire asked about how much each woman exercised and how much they ate.

The questionnaire also contained questions about how much alcohol the women drank, how often they drank, and what types of alcohol they drank, both currently and in the past. The researchers sent out two follow-up questionnaires every 3 to 5 years. These questionnaires asked the women whether they developed type 2 diabetes, what year they were diagnosed, who diagnosed them, and whether they were being treated by diet, drugs, and/or insulin.

Conclusion
The researchers found that blood pressure was lower in the women who drank moderately, but it increased in women who drank more. During the study, a total of 760 new cases of diabetes were diagnosed. The research shows, however, that drinking alcohol in moderate amounts did lessen the risk of developing type 2 diabetes. This is rather significant piece of news as we can now safely drink our favourite wine and not feel guilty about it!








News Jobs & Trends .Pharmaceutical



Pharmaceutical

U.S. Patents Awarded to Inventors in Utah (May 19)
Targeted News Service (subscription)
The abstract of the patent published by the US Patent and Trademark Office states: "The present invention provides cyclic nitro compounds, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or ...

and more »


U.S. Patents Awarded to Inventors in Virginia (May 19)
Targeted News Service (subscription)
The abstract of the patent published by the US Patent and Trademark Office states: "The present invention provides cyclic nitro compounds, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or ...

and more »


FDA Approves Generic Versions of Blood Thinner Plavix
PharmaLive.com (press release)
?For people who must manage chronic health conditions, having effective and affordable treatment options is important,? said Keith Webber, Ph.D., deputy director of the Office of Pharmaceutical Science in the FDA's Center for Drug Evaluation and ...

and more »


Abbott Is Cheap, But AbbVie Will Likely Be Cheaper
Seeking Alpha
This is primarily because in October 2011 Abbott announced it would spin off its pharmaceutical business, which investors (or more accurately, given their entry timing, speculators) appear to have cheered. This new company will be called AbbVie.



PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole ...
SunHerald.com
SAN DIEGO -- POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, presented data today from a Phase 1 study that found that the investigational compound, PA32540, provides faster protection ...

and more »


Junction Report

Seven Companies Receive FDA Approval for Generic Plavix
Junction Report
The FDA said it gave seven pharmaceutical companies the go ahead to sell different generic forms of Plavix, also known as clopidogrel. Plavix is prescribed to millions who take it daily to prevent strokes and heart attacks by not allowing platelets in ...

and more »


POZEN INC. : PA32540 Provides Faster Gastric Acid Reduction Than Enteric ...
4-traders
POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, presented data today from a Phase 1 study that found that the investigational compound, PA32540, provides faster protection compared with ...

and more »


PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole ...
TheStreet.com (press release)
By Business Wire 05/19/12 - 12:15 PM EDT POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, presented data today from a Phase 1 study that found that the investigational compound, PA32540, ...

and more »


PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole ...
MarketWatch (press release)
SAN DIEGO, May 19, 2012 (BUSINESS WIRE) -- POZEN Inc. (NASDAQ:POZN) , a pharmaceutical company committed to transforming medicine that transforms lives, presented data today from a Phase 1 study that found that the investigational compound, PA32540, ...

and more »


Noteworthy Insider Buys Last Week In 2 Beaten Down Biotechs, With 4 Other Buys ...
Seeking Alpha
... Specialty pharmaceutical company Valeant Pharmaceuticals International Inc. (VRX), in which Director Laurence Paul filed SEC Form 4 indicating that he purchased 5000 shares for $255140, increasing his holdings to 37397 shares; Myrexis Inc. (MYRX), ...



Citizens Choice Energy Launches ?Green ChoiceTM? Electric Supply ? a Program ...
Energy Digital (press release)
Source: Citizens Choice Energy Binghamton, NY, May 19, 2012 --(PR.com)-- Citizens Choice Energy makes ?Green Choice??, a 100% Green Electric Supply option, available to all existing and prospective customers. Citizens Choice Energy launched the program ...

and more »


Citizens Choice Energy Launches "Green ChoiceTM" Electric Supply - a Program ...
Utility Products
Binghamton, NY, May 19, 2012 --(PR.com)-- Citizens Choice Energy makes "Green Choice", a 100% Green Electric Supply option, available to all existing and prospective customers. Citizens Choice Energy launched the program in Upstate New York to expand ...

and more »


Citizens Choice Energy Launches ?Green ChoiceTM? Electric Supply ? a Program ...
PR.com (press release)
Binghamton, NY, May 19, 2012 --(PR.com)-- Citizens Choice Energy makes ?Green Choice??, a 100% Green Electric Supply option, available to all existing and prospective customers. Citizens Choice Energy launched the program in Upstate New York to expand ...

and more »


Two Vernon County green events today
La Crosse Tribune
Household hazardous wastes, such as cleaners, pesticides, paints and related products, small amounts of agricultural chemicals and unneeded or expired pharmaceutical products will be accepted at no charge.



FDA opens gates for generic Plavix as patent expires
Pharma Times
The US market for Sanofi/Bristol-Myers Squibb's Plavix has been blown wide open after regulators across the Atlantic gave the green light to copycat versions of the companies' mega-blockbuster bloodthinner. On the day the treatment's patent expired, ...

and more »


Generic Plavix debuts in US
PMLiVE
The FDA has given a green light to several generics of Sanofi and Bristol-Myers Squibb's (BMS) blockbuster antiplatelet drug Plavix, with the first copycat version already starting to ship. The patent on Plavix (clopidogrel) expired yesterday (May 17) ...

and more »


Drug makers given green option
Carbon News
Discoveries made during PhD studies by Victoria University graduate Dr Emma Dangerfield could revolutionise the pharmaceutical industry by allowing drugs to be made in a more environmentally friendly way. Dangerfield's formula allows drug molecules to ...

and more »


Cambridge green-tech company acquired by Toronto firm
Waterloo Record
Originally, it focused on servicing the pharmaceutical industry, but switched to the production of green chemicals in 2010. Combining the companies' two technologies will allow it to extract the maximum value from biomass, David Milroy, chief executive ...



Ariad Pharmaceuticals, ArQule, Exelixis, Aveo, Other Cancer Drug Stocks Fall
Minyanville.com
By Brett Chase May 17, 2012 2:00 pm Shares of Array Biopharma and Onyx Pharmaceuticals are jumping, however, following the release of scientific papers ahead of a medical meeting focused on oncology. MINYANVILLE ORIGINAL Stocks for a number of cancer ...

and more »


Yale Environment 360

Of The Lab and into Products
Yale Environment 360
Paul Anastas pioneered the concept of green chemistry and has led the effort to rethink the way we design and make the products we use. In an interview with Yale Environment 360, he talks about the challenges of bringing this approach to policy making ...

and more »



Green Business News


GlaxoSmithKline is moving to office building in Prague 4
Property Magazine International
The pharmaceutical company previously had its seat in KCP Business Centre Vy?ehrad in Prague 2. The new lease contract in Prague 4 Pankrác was negotiated by the Tenant Representation team of Jones Lang LaSalle in Prague. City Green Court has a very ...



Tranzyme Pharma Announces First Quarter 2012 Financial Results
NCTechNews (press release)
(Research Triangle Park, NC) Tranzyme Pharma (Nasdaq:TZYM), a late-stage biopharmaceutical company focused on discovering, developing and commercializing novel, first-in-class small molecule therapeutics for the treatment of gastrointestinal (GI) ...

and more »


DSM sees green shoots for pharma unit in Q1
InPharm
DSM said its pharmaceutical business unit posted 'weak' financials in the first quarter of 2012, although revenues rose and there are some signs of improvement in the market, according to the company. The Dutch life sciences firm said pharma sales ...



Focus Pharmaceuticals takes 34000 sq ft in Wigan
Place North West
CBRE Global Investors has secured a tenant for the final unit of its Hindley Green Business Park. Focus Pharmaceuticals is set to occupy the 34283 sq ft unit having agreed a 10-year lease. The unit is now being fitted out by Focus following a ...

and more »


Pharma manufacturing news in brief
InPharm
US Food and Drug Administration (FDA) inspectors have given a green light to Cambrex' active pharmaceutical ingredient (API) manufacturing facility in Charles City, Iowa, after visiting the site in February. The GMP certification follows similar ...

and more »


Pharma firms in fine health
VietNamNet Bridge
Foreign pharmaceutical firms hiking stakes in local partners increased recently, with Chile-based CFR International SPA becoming a strategic partner of Domesco Medical Import Export Joint Stock Corporation (DMC), through holding a 44 per cent stake and ...



Codexis gets FDA approval of pharma ingredient
Silicon Valley / San Jose Business Journal
Codexis Inc., a developer of industrial enzymes, received federal US Food and Drug Administration approval for a process co-developed by the company to manufacture sitagliptin, the active pharmaceutical ingredient in Januvia, a Type 2 diabetes drug ...

and more »


FDA Approves Use of Codexis Enzymes in Merck Manufacturing Process
MarketWatch (press release)
REDWOOD CITY, Calif., Apr 24, 2012 (BUSINESS WIRE) -- Codexis, Inc. (NASDAQ:CDXS) , a developer of industrial enzymes to enable the cost advantaged production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that the ...

and more »

 

Related Pharmaceutical articles:

PharmaceuticalMarket Wire - Cynapsus Therapeutics Retains US Investor Relations FirmMay 17, 2012 --

Cynapsus Therapeutics Inc. ("Cynapsus") ( http://www.cynapsus.ca ) (TSX VENTURE:CTH) today announced that it has retained JSDC, Inc. ("JSDC")...full story


Market Wire - Progenra Inc. Selects Dotmatics' Informatics Platform to Improve Its Drug DiscoveryMay 17, 2012 --

Dotmatics , a leading provider of informatics solutions and services to the pharmaceutical and biotechnology industries, announced...full story


Market Wire - Trimel's Tefina(TM) 240-Patient Clinical Trial Opens EnrolmentMay 17, 2012 --

Trimel Pharmaceuticals Corporation (TSX:TRL) (the "Company" or "Trimel") today announced the initiation of patient enrolment into one of the...full story


Market Wire - Ceapro Announces Technical Successes on Supercritical Fluid Drying TechnologyMay 16, 2012 --

Ceapro Inc. (TSX VENTURE:CZO) is pleased to announce that Dr. Bernhard Seifried from Ceapro presented today the latest results obtained from...full story


Business Wire - DBV Technologies: First Quarter 2012 Topline, Scientific Activity and Upcoming Clinical DataMay 15, 2012 --

* Increased R&D Activities Due to Preparation of Phase IIb Launch

* Intense Communication and Scientific Activities Scheduled at...full story


Business Wire - Medivir: New Executive Vice President Commercial AppointedMay 15, 2012 --

STOCKHOLM -- Regulatory News:

Medivir AB (STO:MVIRB), a research-based specialty pharmaceutical company focused on infectious...full story


Business Wire - Research and Markets: Pharmaceutical Industry in China - PEST Framework AnalysisMay 15, 2012 --

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/phpxd3/pharmaceutical_ind) has announced the addition of the...full story


Business Wire - Scil Proteins Enters Drug Discovery Collaboration with Ono for Affilin® TherapeuticsMay 15, 2012 --

HALLE, Germany -- Scil Proteins GmbH, a private biotech company specializing in the research, development and production of recombinant...full story


Business Wire - Aptiv Solutions Announces the Appointment of Luis Gutierrez as Executive Vice President and Chief Commercial OfficerMay 15, 2012 --

RESTON, Va. -- Aptiv Solutions, a biopharmaceutical and medical device development services company, and leader in adaptive clinical trial...full story


Market Wire - ProMetic Receives $4.2 Million Follow-on Order from Major Global Pharmaceutical CompanyMay 15, 2012 --

ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic"or the "Corporation") announced today that it has received a $4.2 million follow-on purchase...full story


 
Gardening Secrets 5 Books - Includes Organic Tomato Secrets
Now Earn Over $30 Per Sale- Demand So High We Had To Raise The Price. 5 Garden Secrets Books Now Featuring Organic Tomato Secrets-converts Great W/ Relevant Build Solar Panels Upsell . Experienced Vendor. More Info At Http://www.lesandjane.com/affiliates

Organic Food Gardening Beginners Manual
103 Page Step-by-step Gardening Manual For Beginners To Learn How To Grow Their Own Healthy, Live, Organic Food - Saving Money & Eating Chemical Free! Great Bonuses With This E-manual. 1stoporganicgardening.com/affiliates.htm

Savvy Organic Shopper's Guide Pays 70%. Earn Up To 82% With Bonuses
Our Step-by-step Guide For Organic Consumers Reveals How To Save $1000's On Organic Food. We Offer Great Affiliate Support. A Soft Sell In Our Economic Times. Earn $44 Per Sale With Upgrade. Organics Is Exploding, Join Now & Ride The Wave!

My Organic Food Garden - 75% Commission
Great Product For The Green Energy / Solar Niche. Affiliate Material Here: Http://www.myorganicfoodgarden.com/affiliates

Organic Garden Spot
Great Ebook In Hot Niche. This Product Explains From A-z How To Set-up, Care For And Grow Your Own Organic Garden. Includes An Affiliate Tools Page With Banners, Emails, Blog Posts, Articles, Product Review, Signature Ads, Promo Site Url's.

New* The Organic Pregnancy Bible - 2010 Edition
Product And Site Look Amazing! High Converting Niche. Easy To Promote. Help Women Give Birth Naturally And Without Drugs! Help Promote The Best Pregnancy Book On CB. Go To Our Affiliate Section For More Resources. Organic Baby Care Series Book

Raised Vegetable Beds For The Organic Garden
A Simple No-nonsense Approach To Building And Maintaining Raised Vegetable Beds In The Organic Garden. "raised Vegetable Beds For The Organic Gardener" Has Over 75 Pages Of Rich Text And Over 80 Images To Help The Reader Make And Maintain A Raised Bed.

Organic Profits
How To Make Money With Organic Gardening

The Organic Gardening Secrets
Covers Nearly Every Bit Of Information About Organic Gardening: From Planning To Designing... From Understanding Your Soil To Improving It... From Choosing Your Plants To Planting Them... From Tending Your Garden To Harvesting Your Crops

Organic Growing And Gardening
This Product Shows You How Gardening Organically Helps In The Preservation Of The Top Soil And Therefore Contributes To The Health Of The Environment. Vegetables Grown Organically By You Are A Lot Safer For You And Your Family. Get 75% On Each Sale!

 

More current readings on : Pharmaceutical

Youtube videos : Pharmaceutical:

SB Do I need an attorney who is experienced in pharmaceutical cases
http://www.youtube.com/watch?v=U5A_1nHcqvQ&feature=youtube_gdata
Big Pharma Revealed The Pharma Watch Review
http://www.youtube.com/watch?v=qCOUaM9bczY&feature=youtube_gdata
pharmawatchreport.plus101.com Big Pharma Revealed The Pharma Watch Review. Compared to other similar types newsletters, Pharma Watch Report leaves them all standing and is a much more dynamic and c....